作者：
Abramson, Vandana G. [1]
;
Oliveira, Mafalda [2]
;
Cervantes, Andres [3]
;
Wildiers, Hans [4]
;
Patel, Manish R. [5]
;
Bauer, Todd M. [6]
;
Bedard, Philippe L. [7]
;
Becerra, Carlos [8]
;
Richey, Stephen [9]
;
Wei, Michael C. [10]
;
Reyner, Eric [11]
;
Bond, John [12]
;
Cui, Na [13]
;
Wilson, Timothy R. [14]
;
Moore, Heather M. [15]
;
Saura, Cristina ;
Krop, Ian E.
作者单位：
Vall dHebron Univ Hosp, VHIO, Dept Med Oncol, Barcelona, Spain
[1]
Genentech Inc, PDSS Global Safety Risk Management Oncol Grp, 1 DNA Way, San Francisco, CA 94080 USA
[2]
Dana Farber Canc Inst, Boston, MA 02115 USA
[3]
Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Div Med Oncol & Hematol,Dept Med
[4]
Genentech Inc, Prod Dev Oncol, 1 DNA Way, San Francisco, CA 94080 USA
[5]
Univ Valencia, Inst Hlth Res INCLIVA, Med Oncol Dept, CIBERONC, Valencia, Spain
[6]
Genentech Inc, Oncol Biomarker Dev, 1 DNA Way, San Francisco, CA 94080 USA
[7]
Texas Oncol, US Oncol Network, Dallas, TX USA
[8]
Sarah Cannon Res Inst Tennessee Oncol PLLC, Nashville, TN USA
[9]
Texas Oncol, US Oncol Network, Ft Worth, TX USA
[10]
Genentech Inc, Dept Clin Pharmacol, 1 DNA Way, San Francisco, CA 94080 USA
[11]
Univ Hosp Leuven, Leuven Canc Inst, Dept Gen Med Oncol, Louvain, Belgium
[12]
CStone Pharmaceut, Suzhou, Peoples R China
[13]
Vanderbilt Univ, Med Ctr, Nashville, TN 37212 USA
[14]
Florida Canc Specialists Sarah Cannon Res Inst, Sarasota, FL USA
[15]
发布时间
2020-03-10
换一批
